This AI tool promises a 'second sight of eyes' to clinicians : NPR

Key Points:

• A clinical AI tool called AI Consult, powered by OpenAI's GPT-4o, was tested in a randomized trial across 16 Kenyan primary clinics, assisting clinical officers by reviewing patient notes and flagging potential concerns with a traffic light system (green, yellow, red).
• The AI tool helped improve the quality of diagnoses and treatment plans, as judged by an independent panel of Kenyan family physicians, at a low cost of 4 cents per patient, serving as a valuable "second pair of eyes" for clinicians.
• Although the study showed a 23% reduction in treatment failures such as death or unresolved symptoms, this result was not statistically significant due to the low baseline rate of such events in primary care, leaving patient outcome benefits unproven.
• Experts praise the study for advancing real-world evaluation of AI in healthcare, especially in low-resource settings, highlighting AI's potential to support healthcare workers by reinforcing protocols, saving time, and possibly expanding access to care.
• The AI recommendations were found helpful about half the time and rarely incorrect, providing clinicians with feedback akin to having a supervisory review, and efforts are underway to implement the tool on a global scale.